BIOTECH100
A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

NitroMed

About NitroMed

NitroMed® is an emerging pharmaceutical company focused on the research, development and commercialization of proprietary pharmaceuticals based on the therapeutic benefits of the naturally occurring molecule nitric oxide. The goal is to become a leading, multi- product pharmaceutical company by developing innovative nitric oxide products

The Company is currently developing a lead nitric oxide-enhancing drug candidate, BiDil, to treat African Americans diagnosed with heart failure.

NitroMed is also applying nitric oxide technology with the goal of developing new pharmaceuticals, as well as safer and more effective versions of existing drugs. The research and development efforts focus on major diseases that are characterized by a deficiency in nitric oxide, such as cardiovascular and inflammatory diseases.

 

PIPELINE FOR NitroMed

 

BiDil -- Heart failure, or end-stage cardiovascular disease

 

 

More Info on NitroMed

 

Home Page

Key Statistics for NitroMed

Basic Chart for NitroMed

Analyst Opinion

Analysts Estimates

NEWS

 
Biotech100 Index
· What are the Requirements to be listed in the Biotech100 Index?
· See the Biotech100 List

Sponsored Links

Clinical Trials
· What is a Clinical Trial?
·Phase I ,-- Phase II, -- PhaseIII
·What is Randomized Control?
 What is a Double Blind Experiment?
·What is the role of the FDA?

 

Key Biotech Terms

 

Biotech Resources

 

Investing in Stocks
· Small Cap Stocks
· Stocks and Bonds
· Biotech100 Index

Careers and Employment
· Biotechnology and Pharmaceutical
· What are the Fastest Growing Careers?

 

Google
 
Web www.biotech100.com
SEARCH THE BIOTECH100 WEBSITE
  
     

 


Copyright © 2005 BIOTECH100.COM. All rights reserved.

email: info@biotech100.com